Physician profile
Farrukh Mohammed
NPI 1356792089
$547.28
in general payments reported to CMS, 2019-2025
7 companies · $67.39 in 2025
The $67.39 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.63 · 2023: $216 · 2024: $172 · 2025: $67.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $260.06 | 2022-2024 | Lifevest |
| Baxter Healthcare | $74.03 | 2023-2025 | Hillrom - Life 2000 Ventilation System, Starling System |
| Pfizer INC. | $65.60 | 2024 | |
| Abbvie INC. | $53.54 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $50.43 | 2022-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $21.84 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $21.78 | 2023 | Lokelma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farrukh Mohammed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.